Disability News and Research

RSS

NHMRC awards Development Grant to speed up chronic wound treatment

A new treatment that could one day benefit burns victims, diabetes sufferers and the elderly - by fast tracking the healing of chronic wounds - has taken another step towards commercialization.

29 Jan 2010

OMT, a viable option for treating back pain in the third trimester of pregnancy

For many pregnant women, it's inevitable. As their pregnancy progresses, tasks that involve the low back often get more difficult. It is harder to bend over, lift, sit or walk for long periods of time, and back pain increases. Treating back pain, and improving daily function relative to tasks that involve the low back is a challenge because pregnant women are limited to treatments that will not create problems for their developing baby.

29 Jan 2010

Tornier and LifeCell commence enrollment in Conexa Reconstructive Tissue Matrix clinical trial

Tornier, Inc., a global leader in extremities and sports medicine orthopaedics, and LifeCell™ Corporation, a KCI Company, announced today the first 13 patients have been enrolled in a multi-center clinical trial to document the clinical value of Conexa™ Reconstructive Tissue Matrix for the surgical repair of large rotator cuff tears. Conexa™ is a porcine-derived tissue matrix with both biologic and mechanical properties that are important to support the repair of injured or surgically reconstructed soft tissue. Launched by Tornier for orthopaedic applications in October of 2008, Conexa™ has been used successfully in approximately 1,500 patients.

28 Jan 2010

AAOS, SOMOS, and OTA host EWI symposium on improving patient care for wounded warriors

Since the beginning of Operations Iraqi Freedom and Enduring Freedom, there have been nearly 36,000 battle- injured warriors, of which approximately 82 percent suffer extremity trauma. Many of these injuries are complicated by the effects of improvised explosive devices which cause injury patterns distinct from civilian trauma. Traditional wound-management guidelines simply fall short.

28 Jan 2010

Medical costs per workers’ compensation claim in Texas were stable in 2007, says WCRI study

Medical costs per workers’ compensation claim in Texas were stable in 2007, following several years of dramatic decreases. The decline in costs resulted from the enactment of two major pieces of reform legislation as well as an increased effort to manage medical care by system payors, according to a new study by the Workers Compensation Research Institute (WCRI).

28 Jan 2010

Workers' compensation status may affect treatment outcomes for herniated disks

Surgery provides better results than nonsurgical treatment for most patients with back pain related to a herniated disk—but not for those receiving workers' compensation for work-related injuries, reports a study in the January 1 issue of Spine.

28 Jan 2010

HSC Foundation invites applications for its 2010 Advocates in Disability Award

In an effort to support the next generation of disability advocates, The HSC Foundation is currently accepting applications for its 2010 Advocates in Disability Award, which recognizes a young person between the ages of 14 and 26 in the Washington, DC Metropolitan area who is dedicated to empowering people with disabilities.

28 Jan 2010

Study shows ActiveHealth's VBID programs increase adherence to medications

ActiveHealth Management (ActiveHealth®), a subsidiary of Aetna, today announced the publication of a paper in the February issue of Health Affairs. The paper demonstrates that properly structured value-based insurance design (VBID) programs can be effective at increasing adherence to drug regimens for specific chronic medical conditions without increasing overall costs.

28 Jan 2010

Automated measurements more reliable in moderate cases of knee degeneration

Scientists have automated the measurement of a vital part of the knee in images with a computer program that performs much faster and just as reliably as humans who interpret the same images.

28 Jan 2010

Study finds RA workers have similar keyboarding speed compared to non-impaired individuals

A recent study by researchers from the University of Pittsburgh found that workers with rheumatoid arthritis (RA) were comparable to non-impaired individuals in keyboarding speed. Individuals who were trained in touch typing demonstrated faster typing speeds than those using a visually-guided ("hunt and peck") method, regardless of impairment.

28 Jan 2010

U.S. study finds improved mortality outcomes for children with rheumatic diseases

A recent study by researchers from the Cleveland Clinic found that the overall mortality rate in the U.S. for all pediatric patients with rheumatic diseases was not worse than the age and sex-adjusted population.

28 Jan 2010

Brighton Hospital signs letter of intent to build an addiction treatment facility in Riyadh

Brighton Hospital, the second-oldest alcohol and drug treatment provider in North America, has signed a letter of intent to begin a long-term management contract with a Saudi Arabian company to build a 291,000 square-foot, 250 bed addiction treatment facility in Riyadh, to serve the entire Islamic Mideast.

28 Jan 2010

Over 8% of medical devices in circulation are counterfeit: WHO

Counterfeit medical products are becoming an international epidemic. According to the World Health Organization (WHO), more than 8% of the medical devices in circulation are counterfeit. The offending products may be assembled from inferior quality components, or worse yet, from fake parts that could contain toxic materials. In either case the dangers are the same. Counterfeit medical devices pose a significant liability to the manufacturers and a health risk to both the patients and healthcare providers that could result in injury, permanent disability, or even death.

28 Jan 2010

Also in global health news: Pakistan's farm land; PMTCT in Kenya; Burkina Faso's maternal health; health care access in Middle East

Pakistan's Foreign Minister Shah Mehmood Qureshi said Tuesday the country plans to sell farmland to foreign investors despite warnings by the U.N. that doing so could compromise farmers' rights, Reuters reports.

28 Jan 2010

Regular exercise associated with greater longevity and reduced risk of age-related conditions

Physical activity appears to be associated with a reduced risk or slower progression of several age-related conditions as well as improvements in overall health in older age, according to a commentary and four articles published in the January 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

27 Jan 2010

FDA approves Victoza to treat type 2 diabetes in some adults

The U.S. Food and Drug Administration today approved Victoza (liraglutide), a once-daily injection to treat type 2 diabetes in some adults.

27 Jan 2010

Elan Drug Technologies issues statement on FDA approval of AMPYRA

Elan Drug Technologies, a business unit of Elan Corporation, plc (NYSE: ELN) today issued the following statement regarding the U.S. Food and Drug Administration (FDA) approval of AMPYRA™ (dalfampridine) as a treatment to improve walking in patients with multiple sclerosis (MS).

25 Jan 2010

Vaccination for children: Pros and cons

ProCon.org, a nonpartisan 501(c)3 nonprofit public charity dedicated to promoting critical thinking, created the new website http://vaccines.procon.org to explore the core question "Should any vaccines be required for children?"

23 Jan 2010

FDA approves fampridine-SR drug for treatment of multiple sclerosis

The Food and Drug Administration has approved the drug fampridine-SR for the treatment of multiple sclerosis. Researchers at the University of Rochester Medical Center (URMC) have been evaluating the effects of the drug in MS for more than 10 years- it is the first medication shown to enhance some neurological functions in people with the disease - and their efforts helped pave the way for today's action by the FDA.

23 Jan 2010

Acorda Therapeutics receives marketing approval from FDA for AMPYRA

Acorda Therapeutics, Inc. today announced that it has received marketing approval from the U.S. Food and Drug Administration (FDA) for AMPYRA™ (dalfampridine), an oral treatment to improve walking in patients with multiple sclerosis (MS).

22 Jan 2010

Disability News and Research

NHMRC awards Development Grant to speed up chronic wound treatment

OMT, a viable option for treating back pain in the third trimester of pregnancy

Tornier and LifeCell commence enrollment in Conexa Reconstructive Tissue Matrix clinical trial

AAOS, SOMOS, and OTA host EWI symposium on improving patient care for wounded warriors

Medical costs per workers’ compensation claim in Texas were stable in 2007, says WCRI study

Workers' compensation status may affect treatment outcomes for herniated disks

HSC Foundation invites applications for its 2010 Advocates in Disability Award

Study shows ActiveHealth's VBID programs increase adherence to medications

Automated measurements more reliable in moderate cases of knee degeneration

Study finds RA workers have similar keyboarding speed compared to non-impaired individuals

U.S. study finds improved mortality outcomes for children with rheumatic diseases

Brighton Hospital signs letter of intent to build an addiction treatment facility in Riyadh

Over 8% of medical devices in circulation are counterfeit: WHO

Also in global health news: Pakistan's farm land; PMTCT in Kenya; Burkina Faso's maternal health; health care access in Middle East

Regular exercise associated with greater longevity and reduced risk of age-related conditions

FDA approves Victoza to treat type 2 diabetes in some adults

Elan Drug Technologies issues statement on FDA approval of AMPYRA

Vaccination for children: Pros and cons

FDA approves fampridine-SR drug for treatment of multiple sclerosis

Acorda Therapeutics receives marketing approval from FDA for AMPYRA

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News